BDBM372435 3,5-diamino-N-(N-(4-(4-((S)-4-amino-3-(3-(bis((2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl)amino)propylamino)-4-oxobutyl)phenyl)butyl)carbamimidoyl)-6-chloropyrazine-2-carboxamide::US10246425, Compound II-d

SMILES NC(=O)[C@H](CCc1ccc(CCCCNC(=N)NC(=O)c2nc(Cl)c(N)nc2N)cc1)NCCCN(C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO

InChI Key InChIKey=RBYHRTDOOGZVHF-CZGVORDXSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 372435   

TargetSodium channel protein type 5 subunit alpha(Homo sapiens (Human))
Parion Sciences

US Patent
LigandPNGBDBM372435(3,5-diamino-N-(N-(4-(4-((S)-4-amino-3-(3-(bis((2S,...)
Affinity DataIC50:  10.6nMAssay Description:One assay used to assess mechanism of action and/or potency of the compounds of the present invention involves the determination of lumenal drug inhi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent